Related Experiment Video
Updated: Jul 9, 2026
07:35
Gene Transfer for Ischemic Heart Failure in a Preclinical Model
Published on: May 15, 2011
[Genetics in ischaemic heart disease].
Anna Wojtczak1, Jadwiga Skretkowicz
1Department of Pharmacogenetics, Medical University of Łódź, Poland. awojt@mp.pl
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego
|December 7, 2007
Summary
Genetic factors significantly influence ischaemic heart disease risk. Identifying gene variants involved in atherosclerosis and thrombosis aids in personalized prevention and treatment strategies for this complex condition.
Area of Science:
- Cardiovascular Genetics
- Molecular Medicine
- Disease Pathogenesis
Background:
- Growing research interest in genetic factors contributing to ischaemic heart disease (IHD) pathogenesis.
- Investigations focus on identifying gene variants associated with increased IHD risk.
- Studies examine polymorphic gene variants impacting atherosclerosis, thrombogenesis, and fibrinolysis.
Discussion:
- Candidate genes for IHD include those involved in lipid metabolism, coagulation, fibrinolysis, and the renin-angiotensin-aldosterone system.
- Inflammatory factors (cytokines, TNF), smooth muscle cell proliferation, and vasoactivation also play significant roles.
- The genetic basis of IHD is multifactorial, with disease manifestation influenced by the accumulation of multiple genetic determinants.
Key Insights:
- Polymorphisms in candidate genes are crucial for understanding IHD development.
- Environmental factors interact with genetic predispositions, modifying clinical presentation.
- Genetic analysis offers potential for tailored prevention and therapeutic interventions in IHD patients.
Outlook:
- Further research into the complex genetic architecture of IHD is warranted.
- Translating genetic discoveries into clinical practice for personalized medicine.
- Exploring gene-environment interactions to refine risk prediction models for IHD.
Related Concept Videos
01:17Ischemic Heart Disease: Overview
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:28Human Genetics
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
01:15Ischemic Stroke ll: Pathophysiology
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...